<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00744796</url>
  </required_header>
  <id_info>
    <org_study_id>102006-017</org_study_id>
    <nct_id>NCT00744796</nct_id>
  </id_info>
  <brief_title>Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty</brief_title>
  <acronym>DSAEK</acronym>
  <official_title>Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) in Patients With Corneal Endothelial Cell Dysfunction: Clinical Outcomes and Diagnostic Imaging Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to report the early clinical outcomes in patients undergoing&#xD;
      Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal edema secondary&#xD;
      to corneal endothelial cell dysfunction, and to correlate this clinical data with the latest&#xD;
      generation of imaging modalities available for the anterior segment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A concurrent study for retrospective as well as prospective cases of patients undergoing&#xD;
      DSAEK procedures for indication of corneal endothelial cell dysfunction. For the&#xD;
      retrospective study, all cases of DSAEK procedures performed at UT-Southwestern for corneal&#xD;
      edema secondary to endothelial cell dysfunction will be considered. The clinical outcomes of&#xD;
      these surgeries will be analyzed and correlated with the anterior segment imaging from each&#xD;
      case. Statistical analysis will then be performed on the data collected. For the prospective&#xD;
      arm of this trial, we propose to recruit up to 200 current patient cases of corneal edema&#xD;
      second corneal endothelial cell dysfunction. These patients will undergo ocular imaging&#xD;
      studies in addition to routine ocular exams performed before surgery and at the discretion of&#xD;
      the investigational physician at 3 to 6-months and 6 to 9-months after surgical treatment.&#xD;
      Various imaging modalities would include corneal topography, pentacam, anterior segment OCT,&#xD;
      wavefront measurement and Tandem Scanning Confocal Microscopy (TSCM). The patients who have&#xD;
      already had the DSAEK procedure done in the past will undergo ocular examination as well as&#xD;
      various imaging studies at their post op follow up visits. All these modalities are routinely&#xD;
      used as standard of care practice and are non-invasive. The data from the ocular examination&#xD;
      and various imaging techniques will be pooled and analyzed at the end of the study in order&#xD;
      to identify the factors that influence the visual outcome. We believe this will help us learn&#xD;
      more about this interesting and innovative technique while at the same time help us improve&#xD;
      the method further in order to obtain better results in future patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Best Spectacle Corrected Visual Acuity (BSCVA)</measure>
    <time_frame>6-9 months Post-Operative</time_frame>
    <description>Best spectacle corrected visual acuity determined using detection of hand motion, counting of displayed fingers and accuracy of Snellen chart reading at specified distances.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Central Corneal Thickness</measure>
    <time_frame>6 to 9 Months Post-Operative</time_frame>
    <description>The central corneal thickness was determined manually by a single investigator from optical coherence tomography (OCT) measurements. A horizontal cross-sectional image with good central reflective light representing the anterior corneal vertex was used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peripheral Corneal Thickness</measure>
    <time_frame>6 to 9 Months Post-Operative</time_frame>
    <description>Peripheral corneal thickness was determined manually by a single investigator using the mean of 2 measurements taken by OCT 3.5 mm from the center of the cornea.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">21</enrollment>
  <condition>Corneal Edema Secondary to Corneal Endothelial Dystrophy</condition>
  <arm_group>
    <arm_group_label>DSAEK: Outcomes in patients with corneal edema</arm_group_label>
    <description>Best spectacle corrected visual acuity and anterior segment optical coherence tomography (OCT) at minimum will be performed in patients who have undergone DSAEK for corneal edema secondary to corneal endothelial dysfunction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DSAEK</intervention_name>
    <description>Endothelial Keratoplasty</description>
    <arm_group_label>DSAEK: Outcomes in patients with corneal edema</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Anterior Segment Optical Coherence Topography (OCT)</intervention_name>
    <description>Non-contact, high resolution, cross sectional imaging of the anterior segment of the eye.</description>
    <arm_group_label>DSAEK: Outcomes in patients with corneal edema</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Best Spectacle Corrected Visual Acuity (BSCVA)</intervention_name>
    <description>Visual acuity determined using a combination of detecting hand motion, counting fingers displayed and reading Snellen charts at specific distances.</description>
    <arm_group_label>DSAEK: Outcomes in patients with corneal edema</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients 18 years or older with a clinical diagnosis of corneal edema secondary to&#xD;
        endothelial cell dysfunction undergoing DSAEK either alone or in conjunction with&#xD;
        phacoemulsification and intraocular lens implantation at the University of Texas&#xD;
        Southwestern Medical Center between May, 2006 and July, 2007.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18 and up, where any age over 89 will be recorded as 'greater than 89',&#xD;
             who have reviewed and understood the study consent form will be invited to participate&#xD;
             in this study.&#xD;
&#xD;
          -  They will be recruited based on diagnosis of corneal edema secondary to endothelial&#xD;
             cell dysfunction undergoing DSAEK either alone or in conjunction with&#xD;
             phacoemulsification and intraocular lens implantation at the University of Texas&#xD;
             Southwestern Medical Center at Dallas.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients younger than 18 years will not be considered for this trial.&#xD;
&#xD;
          -  The study will include all patients (no exclusion criteria) who have undergone and&#xD;
             will undergo DSAEK implantation for corneal edema secondary to corneal endothelial&#xD;
             dystrophy with an effort to determine its success.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vinod Mootha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UTSW Medical Center at Dallas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UT Southwestern Medical Center - Aston Ambulatory Clinic</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 29, 2008</study_first_submitted>
  <study_first_submitted_qc>August 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2008</study_first_posted>
  <results_first_submitted>December 12, 2018</results_first_submitted>
  <results_first_submitted_qc>November 17, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 11, 2020</results_first_posted>
  <last_update_submitted>November 17, 2020</last_update_submitted>
  <last_update_submitted_qc>November 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>V. Vinod Mootha</investigator_full_name>
    <investigator_title>Faculty Sponsor</investigator_title>
  </responsible_party>
  <keyword>Endothelial Dystrophy</keyword>
  <keyword>Fuchs' Endothelial Corneal Dystrophy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Twenty one patients from UT Southwestern Medical Center's Ophthalmology clinic were included.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>DSAEK Group</title>
          <description>Patients who have corneal dystrophy and have elected to have DSAEK performed on his/her eye(s).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Pre-operative</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Post-Operative Day 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Post-Operative 3-6 Months</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Post-Operative 6-9 Months</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>DSAEK Group</title>
          <description>Patients who have corneal dystrophy and have elected to have DSAEK performed on his/her eye(s).</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>Participants in Study</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <description>Collecting the gender information amongst all participants.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Best-Spectacle Corrected Visual Acuity (BSCVA)</title>
          <description>Detection of hand motion, counting of fingers displayed and Snellen chart reading accuracy were used.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Snellen fraction &lt; or = 20/200</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Snellen fraction &lt; or = 20/50 and &gt;20/200</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Snellen fraction &lt; or = 20/20 and &gt;20/50</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hand Motion only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Finger Count only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Best Spectacle Corrected Visual Acuity (BSCVA)</title>
        <description>Best spectacle corrected visual acuity determined using detection of hand motion, counting of displayed fingers and accuracy of Snellen chart reading at specified distances.</description>
        <time_frame>6-9 months Post-Operative</time_frame>
        <population>The number of participant, for analysis, were determined per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>DSAEK Group</title>
            <description>Patients who have corneal dystrophy and have elected to have DSAEK performed on his/her eye(s).</description>
          </group>
        </group_list>
        <measure>
          <title>Best Spectacle Corrected Visual Acuity (BSCVA)</title>
          <description>Best spectacle corrected visual acuity determined using detection of hand motion, counting of displayed fingers and accuracy of Snellen chart reading at specified distances.</description>
          <population>The number of participant, for analysis, were determined per protocol.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>hand motion only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>finger count only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Snellen fraction &lt; or = 20/200</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Snellen fraction &lt; or = 20/50 and &gt;20/200</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Snellen fraction &lt; or = 20/20 and &gt;20/50</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Central Corneal Thickness</title>
        <description>The central corneal thickness was determined manually by a single investigator from optical coherence tomography (OCT) measurements. A horizontal cross-sectional image with good central reflective light representing the anterior corneal vertex was used.</description>
        <time_frame>6 to 9 Months Post-Operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DSAEK Group</title>
            <description>Patients who have corneal dystrophy and have elected to have DSAEK performed on his/her eye(s).</description>
          </group>
        </group_list>
        <measure>
          <title>Central Corneal Thickness</title>
          <description>The central corneal thickness was determined manually by a single investigator from optical coherence tomography (OCT) measurements. A horizontal cross-sectional image with good central reflective light representing the anterior corneal vertex was used.</description>
          <units>micrometer</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="686.6" spread="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Peripheral Corneal Thickness</title>
        <description>Peripheral corneal thickness was determined manually by a single investigator using the mean of 2 measurements taken by OCT 3.5 mm from the center of the cornea.</description>
        <time_frame>6 to 9 Months Post-Operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DSAEK Group</title>
            <description>Patients who have corneal dystrophy and have elected to have DSAEK performed on his/her eye(s).</description>
          </group>
        </group_list>
        <measure>
          <title>Peripheral Corneal Thickness</title>
          <description>Peripheral corneal thickness was determined manually by a single investigator using the mean of 2 measurements taken by OCT 3.5 mm from the center of the cornea.</description>
          <units>micrometer</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="710" spread="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>DSAEK Group</title>
          <description>Patients who have corneal dystrophy and have elected to have DSAEK performed on his/her eye(s).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Vinod Mootha</name_or_title>
      <organization>University of Texas Southwestern Medical Center</organization>
      <phone>214-648-3837</phone>
      <email>peter.chen@utsouthwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

